AstraZeneca is renewing efforts to tackle stigma and amp awareness of COPD this month. (Shutterstock)
November 9, 2022 02:10 PM ESTUpdated November 10, 08:40 AM
Pharma
Marketing

As­traZeneca dou­bles down on COPD aware­ness ef­forts dur­ing na­tion­al aware­ness month

Beth Snyder Bulik

Senior Editor

More than half of peo­ple liv­ing with chron­ic ob­struc­tive pul­monary dis­ease in the US are un­di­ag­nosed. It’s not a brand new prob­lem, but it’s one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times